NCT01904162View on ClinicalTrials.gov

Effect of Age and Gender on the PK and Tolerability of Finafloxacin

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Pharmacokinetic and Tolerability of Finafloxacin
Interventions
DRUG

400 mg finafloxacin (2 x 200 mg tablets)

Trial Locations (1)

85283

Celerion (formerly MDS Pharmaservices), Tempe

Sponsors
All Listed Sponsors
lead

MerLion Pharmaceuticals GmbH

INDUSTRY

NCT01904162 - Effect of Age and Gender on the PK and Tolerability of Finafloxacin | Biotech Hunter | Biotech Hunter